A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence

Name: A Multicenter, Prospective Study of Perioperative Finotonlimab Combined With Bevacizumab in Resectable Hepatocellular Carcinoma Patients With High-Risk Factors for Recurrence
License: Public Domain

Tongji Hospital

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

hcc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 268025
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.